F2 Vision SCS

Insider Reports History

Entity
Individual
Location
74 Grand Rue, Luxemburg, Luxembourg
Signature
/s/ Alain Renard /s/ Christian Francois, for F2 Vision SCS
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by F2 Vision SCS:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.26M $15.6M $12.46 Aug 4, 2022 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.14M $14.2M $12.46 Aug 2, 2022 By Globeways Holdings Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622K $7.75M $12.46 Aug 2, 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537K $6.7M $12.46 Aug 2, 2022 By F2 Bioscience I 2017 Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325K $4.05M $12.46 Aug 2, 2022 By F2 MG Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 215K $2.68M $12.46 Aug 2, 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 208K $2.59M $12.46 Aug 2, 2022 By Morana Jovan-Embiricos
Cullinan Oncology, Inc. 10%+ Owner Common Stock 105K $1.31M $12.46 Aug 2, 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71.6K $892K $12.46 Aug 2, 2022 By F2 Bio TD, LLC

Insider Reports Filed by F2 Vision SCS

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Aug 2, 2022 3 -$712K 4 Aug 4, 2022 10%+ Owner
CGEM Cullinan Oncology, Inc. May 12, 2022 4 -$4.05M 4 May 16, 2022 10%+ Owner
CGEM Cullinan Oncology, Inc. Jan 11, 2022 1 $0 4 Jan 13, 2022 10%+ Owner